JPWO2021201036A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021201036A5
JPWO2021201036A5 JP2022512589A JP2022512589A JPWO2021201036A5 JP WO2021201036 A5 JPWO2021201036 A5 JP WO2021201036A5 JP 2022512589 A JP2022512589 A JP 2022512589A JP 2022512589 A JP2022512589 A JP 2022512589A JP WO2021201036 A5 JPWO2021201036 A5 JP WO2021201036A5
Authority
JP
Japan
Prior art keywords
optionally substituted
methyl
group
carbon atoms
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022512589A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021201036A1 (https=
JP7684282B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/013694 external-priority patent/WO2021201036A1/ja
Publication of JPWO2021201036A1 publication Critical patent/JPWO2021201036A1/ja
Publication of JPWO2021201036A5 publication Critical patent/JPWO2021201036A5/ja
Application granted granted Critical
Publication of JP7684282B2 publication Critical patent/JP7684282B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022512589A 2020-03-31 2021-03-30 ヒドロキシピロリジン誘導体およびその医薬用途 Active JP7684282B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020065410 2020-03-31
JP2020065410 2020-03-31
PCT/JP2021/013694 WO2021201036A1 (ja) 2020-03-31 2021-03-30 ヒドロキシピロリジン誘導体およびその医薬用途

Publications (3)

Publication Number Publication Date
JPWO2021201036A1 JPWO2021201036A1 (https=) 2021-10-07
JPWO2021201036A5 true JPWO2021201036A5 (https=) 2024-04-26
JP7684282B2 JP7684282B2 (ja) 2025-05-27

Family

ID=77927631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022512589A Active JP7684282B2 (ja) 2020-03-31 2021-03-30 ヒドロキシピロリジン誘導体およびその医薬用途

Country Status (5)

Country Link
US (1) US20230312542A1 (https=)
EP (1) EP4129402A4 (https=)
JP (1) JP7684282B2 (https=)
CN (1) CN115298173A (https=)
WO (1) WO2021201036A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240327392A1 (en) * 2021-06-25 2024-10-03 Albius Sciences Alpha Private Limited Heterocycloalkyl-substituted polyheteroazole derivatives as medicaments for treating and/or preventing rs virus infections
KR20240148807A (ko) * 2022-03-22 2024-10-11 옵쉐스트바 스 아그라니첸너이아트볫스트벤너스찌유 "빅-즈다로비예쥐보트니흐" 메데토미딘 및 그 유도체의 제조 방법
CN119677735A (zh) * 2022-05-11 2025-03-21 基因泰克公司 作为vhl配体的苯并噻唑化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2425288A1 (en) 2000-10-11 2002-05-02 Sander G. Mills Pyrrolidine modulators of ccr5 chemokine receptor activity
AU2006223482A1 (en) 2005-03-14 2006-09-21 Janssen Pharmaceutica, N.V. Process for the preparation of opioid modulators
EP2238128B1 (en) 2007-12-26 2012-08-22 Sanofi Heterocyclic pyrazole-carboxamides as p2y12 antagonists
PL2242759T3 (pl) 2008-02-06 2013-06-28 Astrazeneca Ab Związki
EP2384328B1 (en) 2008-11-27 2013-02-13 Boehringer Ingelheim International GmbH 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and process for preparing them
US8673954B2 (en) * 2009-02-27 2014-03-18 Enanta Pharmaceuticals, Inc. Benzimidazole derivatives
EA020031B1 (ru) * 2009-06-11 2014-08-29 Эббви Бахамаз Лтд. Противовирусные соединения
AU2010274001A1 (en) * 2009-07-16 2012-02-23 Vertex Pharmaceuticals Incorporated Benzimidazole analogues for the treatment or prevention of Flavivirus infections
EP2305660A1 (en) 2009-09-25 2011-04-06 Almirall, S.A. New thiadiazole derivatives
WO2011084402A1 (en) 2009-12-21 2011-07-14 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
EP2752410B1 (en) 2011-10-25 2016-08-31 Shionogi & Co., Ltd. Heterocycle derivative having pgd2 receptor antagonist activity
KR102668696B1 (ko) * 2012-01-12 2024-05-29 예일 유니버시티 E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법
US9783527B2 (en) 2014-09-16 2017-10-10 Abbvie Inc. Indazole ureas and method of use
WO2019084026A1 (en) * 2017-10-24 2019-05-02 Genentech, Inc. (4-HYDROXYPYRROLIDIN-2-YL) -HETEROCYCLIC COMPOUNDS AND METHODS OF USE
IL281188B2 (en) * 2018-09-07 2025-08-01 Arvinas Operations Inc Polycyclic compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides

Similar Documents

Publication Publication Date Title
JP7589191B2 (ja) 新規の阻害剤
AU2006224765B2 (en) CIS-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
AU2009273105B2 (en) Azole compound
JP5180099B2 (ja) 置換イミダゾール誘導体、組成物ならびにptpアーゼ阻害剤としての使用方法
JPWO2021201036A5 (https=)
US9493446B2 (en) Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
JP4764418B2 (ja) アルツハイマー病の治療のためのβ−セクレターゼ阻害剤として有用な2,4,6−置換ピリジル誘導体化合物
EP2811997B1 (en) Substituted prolines/piperidines as orexin receptor antagonists
KR100442561B1 (ko) 5산화2질소신타아제의억제제로유용한환상아미디노제
AU2008340113B2 (en) Triazole oxadiazoles derivatives
MXPA06009023A (es) Compuestos poliheterociclicos y su uso como antagonistas del receptor de glutamato metabotropico.
CN102395567A (zh) 在治疗糖尿病和肥胖症中用作的tgr5激动剂的三唑和咪唑衍生物
JPH072851A (ja) 5員複素環化合物、それらの調製方法及びこれらの化合物を含む医薬組成物
BRPI0721163A2 (pt) Compostos e composições como inibidores de atividade de receptor 1 canabinóide.
EP1501809A1 (en) Triazole derivatives as tachykinin receptor antagonists
MX2008014193A (es) Inhibidores del factor xa.
CZ20013736A3 (cs) Derivát karbamové kyseliny a jeho pouľití jako metabotropních glutamátových receptorových ligandů
WO2012054510A1 (en) Oxadiazole compounds which inhibit beta-secretase activity and methods of use thereof
ES2505190T3 (es) Derivados de piperidina como antagosistas del receptor nk3
CN101528740B (zh) 作为大麻素cb1受体拮抗剂的杂芳基-吡唑衍生物
AU616708B2 (en) 4-heteropentacyclic-4-{n-(phenyl)amido}piperidine derivatives and pharmaceutical compositions and method employing such compounds
CN105102454A (zh) 作为cetp抑制剂的新型噁唑烷酮衍生物、其制备方法和包含其的药物组合物
CN100491355C (zh) 带有五元环基团的环状二胺化合物
US7875647B2 (en) Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists